Craft

Quantum Genomics

Stock Price

€0.1

2024-10-29

Market Capitalization

€2.5 M

2024-10-29

Quantum Genomics Summary

Company Summary

Overview
Quantum Genomics is a biopharmaceutical company. It is engaged in the research and development of drugs for the treatment of cardiovascular diseases. The company develops drugs primarily to treat high blood pressure and heart failure. 
Type
Public
Status
Active
Founded
2006
HQ
Paris, FR | view all locations
Website
http://www.quantum-genomics.com/www/en/
Cybersecurity rating
Sectors

Key People

  • Carole Wassermann

    Carole Wassermann, Director

    • Fabrice Balavoine

      Fabrice Balavoine, Vice President Research and Development

    • Benoît Gueugnon

      Benoît Gueugnon, Director, Administratif, Financier

    • Frederic Duchesne

      Frederic Duchesne, Director

      LocationsView all

      1 location detected

      • Paris, IDF HQ

        France

        33 Rue Marbeuf

      Quantum Genomics Financials

      Summary Financials

      Net income (FY, 2024)
      (€8.9M)
      Cash (FY, 2024)
      €301.0K
      EBIT (FY, 2024)
      (€1.5M)
      Enterprise value
      $4.8M

      Footer menu